ADOZIT 200
Therapeutic Class
Antibiotics (Macrolide)
Indications
ADOZIT 100/200 is indicated for For the management of community-acquired pneumonia, uncomplicated genital infections due to Chlamydia trachomatis. Bronchitis etc DOSAGE Children over 45 kg body weight and adults, including elderly patients: The total dose of azithromycin is 1500 mg which should be given over three days (500 mg once daily). In uncomplicated genital infections due to Chlamydia trachomatis, the dose is 1000 mg as a single oral dose. In children under 45 kg body weight: Adozit 200 are not suitable for children under 45 kg.
Chemical Composition
Each 5ml contains Azithromycin Dihydrate USP eq. to Azithromycin 200mg
Packaging
30ml / bot
Dosage & Administration
From 6month of age, 10-12mg/kg/day for 3-5days or as directed by physicians.
Contraindications
ADOZIT 100/200 is contra-indicated in patients with a known hypersensitivity to azithromycin or any of the macrolide or ketolide antibiotics, erythromycin, or to any excipients thereof as (for example) listed in Section 6.1 List of Excipients.
Side Effects
Anorexia, Nervousness, Aggression, anxiety, Dizziness, headache, paraesthesia, dysgeusia, Diarrhoea, abdominal pain, nausea, flatulence etc.
Drug Interaction
Antacids: In a pharmacokinetic study investigating the effects of simultaneous administration of antacid with azithromycin, no effect on overall bioavailability was seen, although peak serum concentrations were reduced by approximately 25%. In patients receiving both azithromycin and antacids, the drugs should not be taken simultaneously. Cetirizine: In healthy volunteers, co-administration of a 5-day regimen of azithromycin with cetirizine 20 mg at steady-state resulted in no pharmacokinetic interaction and no significant changes in the QT interval. Didanosine (Dideoxyinosine): Co-administration of 1200 mg/day azithromycin with 400 mg/day didanosine in 6 HIV-positive subjects did not appear to affect the steady-state pharmacokinetics of didanosine as compared with placebo.